Flagship Pioneering Fellows Progam

Similar documents
Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

Technology Leadership Course Descriptions

INVENT, INNOVATE AND IMPACT THE FUTURE CAREERS AT SRI: CENTER FOR VISION TECHNOLOGIES

Dynamic Cities and Creative Clusters

TRANSFORMATIONAL GOALS FOR THE 21ST CENTURY

FDA Centers of Excellence in Regulatory and Information Sciences

Omeros Raises More Than $63 Million in Financing

COURSE 2. Mechanical Engineering at MIT

THE CENTER FOR WOMEN S ENTREPRENEURIAL LEADERSHIP AT BABSON

Data Sciences for Humanity

An Introduction to China s Science and Technology Policy

INTEL INNOVATION GENERATION

Technology Transfer: Working with Industry at MIT. 10 February 2009 Kenneth A. Goldman Manager, Corporate Relations MIT Industrial Liaison Program

Wolfpack Investor Network. Investing in Our University s Best and Brightest

9/27/2013. Office of Technology Transfer Overview. Impacts from NC State Technology Transfer. NC State s Office of Technology Transfer

Connections with Leading Thinkers. Frank Bobe of the Wyss Institute at Harvard University

WHY ACCOUNTANCY & SOCIAL DESIGN

The future of Research Universities in Asia: Reading the water well AND creating exciting new streams

FINC915 Venture Lab Participating Firms: FALL 2010

Making lives better every day. This is UCB

As our state s flagship university, KU s MISSION is to lift students and society

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Creating a Social Investment Fund in Israel: Policy and Financial Considerations

Space Challenges Preparing the next generation of explorers. The Program

WITH Woodside. The Woodside Innovation & Technology Hub. Building a community of world-class innovators to unlock tomorrow s growth opportunities.

PURDUE SCHOOL OF ENGINEERING AND TECHNOLOGY AT IUPUI

IMPACT REPORT

INTERNET OF THINGS IOT ISTD INFORMATION SYSTEMS TECHNOLOGY AND DESIGN

Experiences of an aspiring young scientist-entrepreneur

PHARMA S NEW PHASE. Technological integrators play as crucial a role as banks in Big Pharma s latest M&A boom. They re back.

NIHR ROADSHOW FOR MEDTECH SMES

Getting Started. This Lecture

ADVANCING KNOWLEDGE. FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020

JURY BOARD BUSINESS/INVESTMENT. Pascal BECACHE Founding President, PBS, Healthcare Industry STRATEGY/BUSINESS

A PLATFORM FOR INNOVATION

Shaping the future. Aalto University Vision, Mission and Strategies

Understanding Venture Capital

An Introdcution to Horizon 2020

CHEMISTRY AND PHARMACEUTICALS PATENT ATTORNEYS TRADE MARK ATTORNEYS

Getting Value From Research:

SAMPLE PROGRAM AGENDA

Winners of the McRock IIoT Awards 2018 Announced

HARNESSING TECHNOLOGY

Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Executive Master in Digital Transformation & Innovation Leadership Digital up-skilling to transform and lead in business.

Digital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver

Creating Innovation Driven by Social Needs Anchored in the Future

Scottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund

Education and Culture

Scripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011

University of Oxford Executive Finance Programmes

TAB V. VISION 2030: Distinction, Access and Excellence

Top 50 Emerging Technologies & Growth Opportunities

MCGILL CENTRE FOR THE CONVERGENCE OF HEALTH AND ECONOMICS (MCCHE)

Start your adventure here.

FINC915 Venture Lab Participating Firms: FALL 2009

Research and Innovation Strategy and Action Plan UPDATE Advancing knowledge and transforming lives through education and research

LEADING DIGITAL TRANSFORMATION AND INNOVATION. Program by Hasso Plattner Institute and the Stanford Center for Professional Development

Innovative Business Incubation Foster the Growth of Technology

In this first of a series of MVision Insights, we commissioned research from the London Business School into the participation of women in the US

THE RISKY CITY: INNOVATION IS THE OUTCOME. CREATIVITY IS THE PROCESS

Utrecht Region. A key role in the Netherlands medical technology industry. Why locate your medical technology company in the Utrecht Region?

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Master in Management and Engineering (M. Sc.)

CASI Pharmaceuticals, Inc.

An Experienced Approach to Private Equity

STRATEGIC FRAMEWORK Updated August 2017

Innovation in the Canadian Agri- Food Sector

Welcome. There s no more exciting time, and no more exciting place, to put your talents to work.

EXPLORING HOW ENGINEERING ENTREPRENEURSHIP COMPETENCIES ALIGN WITH ABET CRITERION 3A-K

Knowledge Exchange Strategy ( )

Spring 2008 Participating VC firms

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

WHAT SMALL AND GROWING BUSINESSES NEED TO SCALE UP

Class I - Innovation. Disruptive Innovation Why Lawyers Matter

Canada s Robotics Moment

A Roadmap For Building Indigenous Digital Excellence: Looking To 2030

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry

Space Challenges Preparing the next generation of explorers. The Program

Triton Technology Fund

DANUBE INNOVATION PARTNERSHIP

PROPOSAL FOR THE HARVARD LAW SCHOOL PUBLIC SERVICE VENTURE FUND. Future of Legal Ed2 Conference Harvard Law School October 15-16, 2010

Venture Capital Academy

Translational scientist competency profile

Horizon the new EU Framework Programme for Research and Innovation

LEADING DIGITAL TRANSFORMATION AND INNOVATION. Program by Hasso Plattner Institute and the Stanford Center for Professional Development

THIS IS RESEARCH. THIS IS AUBURN RESEARCH.

Vice Chancellor s introduction

>> PERSPECTIVES_2012 THE FUTURE OF CHEMICAL AND PHARMACEUTICAL PRODUCTION IN GERMANY CMF JUNE 19, 2012 FACILITATED BY DR. MICHAEL REUBOLD, CHEMANAGER

Engineering Innovation Stanford EE15n January 6, 2015 Judy Estrin, CEO, JLabs

U15 Pre-Budget 2018 Submission

4 Who we are: 24 Careers: The company. Careers for experienced professionals. Shareholders/investors. Careers for recent graduates.

THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES

Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization

Mission Agency Perspective on Assessing Research Value and Impact

Life Sciences Outlook. New York City 2016

TRANSLATIONAL SCIENCE

Pathfinders Quest Delhi, 2017

Investment Management Initiative Clubs of Interest General information about clubs that are related to our project

Transcription:

Flagship Pioneering Fellows Progam Where Exceptional Innovators Help Create the Next Disruptive Life Science Startups

A Unique Life Science Innovation Enterprise Flagship Pioneering is a unique life science innovation enterprise founded with the mission to conceive, resource and grow first-in-category companies to transform human health and sustainability. Entrepreneurial scientists at heart, we explore hundreds of venture hypotheses through the firm s innovation foundry, Flagship Labs. There, Flagship s worldclass team of scientists, innovators and professional entrepreneurs refine and perfect those few hypotheses that will become the market-disrupting companies of the future. Our ventures discover new ways of understanding and therapeutically approaching disease, creating unprecedented biotechnologies in the forms of new drug modalities and generating new product-platform technologies. These are the companies that push the boundaries of science, redefine what is possible, and create new hope and better lives for patients. Flagship Labs is not an incubator or accelerator. It is the first institutional platform to systematize entrepreneurial innovation and build those innovations into first-in-category, unprecedented companies. We originate, iterate, found and build. The ideas are ours. We harness science and entrepreneurialism to envision alternative futures, beginning with seemingly unreasonable propositions and navigating to transformational outcomes through an iterative, evolutionary methodology. We call this process pioneering. With an impressive track record since its founding in 2000, Flagship has: Fostered or developed over 100 companies, including Moderna Therapeutics, Seres Therapeutics, Indigo Agriculture, Rubius Therapeutics and many more A pipeline of 160+ programs across all stages and 14 therapeutic areas across Flagship's companies 1,000s of patents filed and/or granted across our ecosystem of companies Created innovation alliances with market-leading companies such as Merck, AstraZeneca, Nestle Health Science, and Bayer s Division of Crop Science

We Use a Unique Darwinian Process for Company Creation A Pioneering Portfolio We Make Life-Changing Breakthroughs a Reality We begin by asking what if? and why not?, explicitly distancing ourselves from the boundaries of current knowledge and products to determine where new technologies could solve global problems and transform large markets in human health and sustainability. This creates sets of opportunities that are effectively untouched true white spaces. We then work together to invent or identify breakthrough technologies in these disruptable intersections, while carefully protecting our IP. The result: companies that are first in-class and best-in-class. We Practice the Discipline of Entrepreneuring The difference between entrepreneuring and entrepreneurship is the difference between doing and being. We apply repeatable and transferable techniques honed by the experience of founding and capitalizing over 100 companies to the systematic creation and optimization of any venture. We have consolidated the learnings that serial entrepreneurs gain over decades and apply them to every company we create. We Build Field-Dominating IP Estates From the earliest stages of a new company s conception, we develop a comprehensive intellectual property strategy to strongly protect our innovations against imitation and follow-on competition. The intellectual property we create not only fuels the immediate projects at hand, but also provides our team with unique insights and a sustainable advantage within the targeted market sector. We Work with an Ecosystem of Experts for Ideation and De-Risking We leverage our expansive network of academics, technology practitioners and industry professionals to iterate ideas, reduce risk, and accelerate the creation of disruptive new ventures. Our ecosystem helps inform our development of the selection pressure we use to evolve ideas into startups. We bring discipline and an investment mindset into the earliest stages and apply it consistently throughout the four phases of the Flagship Labs process. Flagship has consolidated the learnings that serial entrepreneurs gain over decades, and we systematically create and optimize every company we originate. Through our four-phased, iterative, Darwinian process, we have created some of the leading companies in human health and agriculture, including: Building on Flagship s expertise in the microbiome, our team of scientists began to look into the complex world of bacteria living in and on plants. In Flagship Labs, Indigo Agriculture was born to harness these beneficial microbes to naturally promote plant health and improve productivity. Today, the company has multiple products on the market and was named a Technology Pioneer by the World Economic Forum. Originated in Flagship Labs, Moderna is working to deliver on the promise of mrna science to create a new generation of transformative medicines for patients. PHASE 1 Explorations Hypothesis Generation PHASE 2 ProtoCo Feasibility Testing PHASE 3 NewCo Internal Venture PHASE 4 GrowthCo Spin-out Venture The result of an Exploration, Seres Therapeutics (NASDAQ: MCRB) is the world s leading microbiome therapeutics company, with treatments in clinical trials for recurrent Clostridium difficile and ulcerative colitis. The company has received breakthrough designation from the FDA. White space seeded by multiple hypotheses Network engaged to iterate/refine Project team focused on Proof of Concept Patent generation Team formation Network engaged to critique and evolve Execute product and platform development plan Assemble broader team and board Flagship leadership and founding team CEO recruited BOD governance Separate from Flagship resource Grow and thrive Images courtesy of Indigo Agriculture, Moderna Therapeutics, and Seres Thereaputics.

Not Your Typical Fellowship A Program Rooted in Creative, Entrepreneurial Science If you re considering an alternative path from academia that allows you to remain engaged in creative science, Flagship s Fellows Program offers a balance of freedom of thought, imagination, science rooted in reality and rigorous business practice. The Flagship Fellows Program is unlike a traditional internship or academic fellowship. It provides a rare opportunity to do something different with your graduate training and to apply your scientific expertise, entrepreneurial talents, and selfstarter mentality toward creating new ventures. Science is at the core of Flagship s fellowship program a new way of thinking about cutting-edge science that goes beyond splashy headlines to actually impact the health of people and our planet. Each day, Fellows work closely with Flagship s team of entrepreneurial scientists to explore big ideas, look differently at scientific literature, and generate new vantage points for companies with world-changing potential. FELLOWS PROGRAM BY THE NUMBERS 10+ 160+ 1,000s Programs Completed Fellow Graduates Of ideas explored in Life Sciences and Sustainability Experience the Art of Creating First-in-Category Companies We are looking for outstanding, creative scientists, engineers, inventors, and budding entrepreneurs who want to stay rooted in science while pushing the creative bounds of an alternative path. Fellows work hand-in-hand with our seasoned professionals through the Exploration phase of Flagship s process the point at which we explore ideas with world-changing potential and create a foundational understanding of existing science and opportunity for original experimentation. When you work with us you will experience our unique fourphased methodology for creating first-in-class, first-incategory life science companies. Key benefits include: Tap into our unique position in the innovation ecosystem Network with our team of experts across academia and industry Explore the cutting edge of science and technology Experience the startup world and our unique company creation process Learn how to ideate a thought into a new venture Find practical applications for your skills and expertise Learn from your peers and some of the brightest minds in the business Work in the heart of the vibrant Cambridge, Massachusetts/Kendall Square community Sample Curriculum Each Flagship Fellows Program varies in the exact curriculum as we tackle new and exciting areas of development, science and current events each year. Past examples include: Meeting with leaders from Flagship s portfolio companies, such as Editas Medicine, Moderna Therapeutics, Syros Pharmaceuticals and others Meeting with former Fellows who have graduated to new careers in developing fields Talks from and discussion with experts in functional life science areas such as intellectual property, clinical trials, drug development, and other subjects Conversations with dozens of leading scientists and subject matter experts around the world throughout the Exploration process Offsite visits to Flagship pioneering portfolio companies Social events within summer cohort and Flagship at large Gateway to Opportunities in the Life Sciences The Flagship Pioneering Fellows Program is an unparalleled launching point for careers in life science. Whether your goal is to pursue a career at the intersection of science and business, try something different, or gain exposure to Flagship s worldclass network, the Fellows Program offers a unique set of desirable skills and experiences for your next step. Over 160 graduates of our Fellows Program have gone onto exciting careers in life science, including: Science-centric roles at leading academic and research institutions, such as Stanford, Memorial Sloan Kettering Cancer Center, the Broad Institute, Whitehead Institute, MIT, Koch Institute and the Chan Zuckerberg Biohub CEOs/Founders of their own companies and startups Consultants at leading firms such as Bain Consulting, McKinsey, and Boston Consulting Group Scientists and leaders in global biotech and pharmaceutical companies such as AstraZeneca, Alnylam and Biogen Investment professionals at venture firms such as the Column Group and Apple Tree Partners Foundational, ground-level positions such as Senior Scientist, Business Development, and Head of Research at cutting-edge Flagship startups. Recent examples include Evelo Biosciences, Foghorn Therapeutics, Sigilon Therapeutics, Indigo Agriculture and Inari Agriculture Positions within the Flagship Labs origination and innovation group

Details and How to Apply If you are interested in helping to create the next generation of disruptive companies, then the Flagship Fellows Program might be right for you. Full time: June 3, 2019 August 23, 2019 Fellows will receive a stipend Program takes place at the Flagship Pioneering offices near Kendall Square: 55 Cambridge Parkway, Suite 800 E, Cambridge, MA 02142 Learn Flagship s process for generating and refining actionable pioneering hypotheses Develop your creativity, adaptability, and ability to innovate Work directly with highly-experienced Flagship team members a group of widely recognized scientists, entrepreneurs and executives Build relationships and expand your network with a diverse and highly successful group of peers Hear from experts and leaders from Flagship s extended network, such as CEOs of leading companies Gain exposure to leaders in science and business providing a highly potent platform for personal growth Requirements Deep scientific or business background aimed at life sciences Academic excellence and self-starter mentality: confident, passionate, persuasive Creativity and the ability to solve complex scientific and business problems Currently a graduate or post-graduate student (MS, PhD, MD, MBA, etc.) with a scientific background from a top university Preferably no more than 1-2 years away from full-time employment APPLY ONLINE www.flagshippioneering.com